cambridgeindependent2d
AstraZeneca revenues rise to $54bn as it enters ‘unprecedented’ period for company
AstraZeneca is expecting Phase III trial data for seven new medicines in 2025, its CEO said as he confirmed the company’s ...
The NHS ‘double whammy’ undermining a £108bn British industry
Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...
Armed robbery in Revesby1d
Musk Discusses Tech Support Governance at Dubai Summit
Wearing a "Tech Support"-printed T-shirt, Elon Musk virtually took to the stage on the final day of the World Governments ...
Business Wire1d
Elon Musk Talks ‘Tech Support’ Governance as World Leaders Champion Innovation-Driven Reforms at Dubai Summit
Wearing a “Tech Support”-printed T-shirt, Elon Musk virtually took to the stage on the final day of the World Governments ...
pharmaphorum3d
AstraZeneca reveals $570m investment in Canada
Chief executive Pascal Soriot said the investment reflects the emergence of Canada as a hot spot for life sciences innovation, as well as AZ's confidence in its clinical pipeline and the ...
pharmaphorum3d
AZ says recovery to continue to despite patent expiry and Brexit headwinds
Under the leadership of CEO Pascal Soriot the company has spent the last few years rebuilding its pipeline, selling off old drugs, and bringing new drugs to market as patents expired on former ...
Hosted on MSN5d
Peer demands answers on AstraZeneca deal collapse
Pascal Soriot, chief executive of AstraZeneca, said there was no rift with the government but the deal was no longer ...